Literature DB >> 6731820

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography.

D R Eyre, T J Koob, K P Van Ness.   

Abstract

An HPLC method for quantifying the 3-hydroxypyridinium crosslinks of collagen is described. It can be applied to crude hydrolysates of all types of connective tissue. Mineralized tissues can be hydrolyzed directly and analyzed without interference from the mineral ions. The hydroxylysyl (HP) and lysyl (LP) forms of hydroxypyridinium residue were resolved on a reverse-phase C18 column using a gradient of acetonitrile in water and 0.01 M n-heptafluorobutyric acid as an ion-pairing agent. The crosslinking amino acids were accurately quantified down to 2 PM (1 ng) injected, by detecting their natural fluorescence with a spectrofluorometer. Tissues in which hydroxypyridinium crosslinks were plentiful included all forms of cartilage, bone, dentin, ligament, tendon, fascia, intervertebral disc, lung, gut, cervix, aorta, and vitreous humor. Among normal tissues, LP, the minor form of the crosslink, was present in significant amounts relative to HP only in bone and dentin. Both crosslinks were essentially absent from skin, cornea, rat tail tendon, and basement membranes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731820     DOI: 10.1016/0003-2697(84)90101-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  97 in total

1.  The Urinary Excretion of Pyridinium Cross-links as Markers of Bone Meta stasisin Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women.

Authors:  Mariana Cifuentes; Claudia S Riedt; Robert E Brolin; M Paul Field; Robert M Sherrell; Sue A Shapses
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

3.  Estrogen prevents the reduction in fractional calcium absorption due to energy restriction in mature rats.

Authors:  Mariana Cifuentes; Juan P Advis; Sue A Shapses
Journal:  J Nutr       Date:  2004-08       Impact factor: 4.798

Review 4.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

5.  Techniques to Assess Collagen Synthesis, Deposition, and Cross-Linking In Vitro.

Authors:  Tamara Rosell-García; Fernando Rodriguez-Pascual
Journal:  Methods Mol Biol       Date:  2021

6.  Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage.

Authors:  R A Bank; M T Bayliss; F P Lafeber; A Maroudas; J M Tekoppele
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  Enhanced prolylhydroxylase activity in the posterior annulus fibrosus of canine intervertebral discs following long-term running exercise.

Authors:  K Puustjärvi; T Takala; W Wang; M Tammi; H J Helminen; V Kovanen
Journal:  Eur Spine J       Date:  1993-10       Impact factor: 3.134

8.  Energy restriction reduces fractional calcium absorption in mature obese and lean rats.

Authors:  Mariana Cifuentes; Amy B Morano; Hasina A Chowdhury; Sue A Shapses
Journal:  J Nutr       Date:  2002-09       Impact factor: 4.798

9.  Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.

Authors:  Paige K Berger; Norman K Pollock; Emma M Laing; Valerie Chertin; Paul J Bernard; Arthur Grider; Sue A Shapses; Ke-Hong Ding; Carlos M Isales; Richard D Lewis
Journal:  J Nutr       Date:  2015-10-21       Impact factor: 4.798

10.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.